Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1349 (LINC01349)

Target
LINC01349
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA, Non-protein coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 1349 (LINC01349) is a non-protein-coding RNA gene classified as a lincRNA[1]. LincRNAs are transcripts longer than 200 nucleotides and fall under the broader category of long non-coding RNAs (lncRNAs)[7][9]. They do not overlap with protein-coding genes and are generally implicated in the regulation of gene expression at transcriptional and epigenetic levels, although the specific biological role or disease association of LINC01349 is not described in the available literature or genetic resources as of 2024[1][7][9]. Most lincRNAs are not considered direct therapeutic targets but are the subject of research for their regulatory functions and potential as biomarkers or modifiers of disease pathways[5][9]. There is no evidence that LINC01349 is directly involved in signaling, cell proliferation, apoptosis, or any major disease, nor is it a target for any approved drugs as of September 2025[1].

Other names
LINC01349
02

Biological functions

Regulation of gene expression (general function of lincRNAs)Epigenetic regulation (by analogy to the actions of other lincRNAs)Other (potential involvement in chromatin modification, but specific functions for LINC01349 are not established)
03

Disease associations

Other (No documented direct association with diseases such as cancer, inflammation, or other specific conditions as of now[1]. Analogous lincRNAs can sometimes be implicated in cancer or immune regulation[3][5][9], but not specifically LINC01349.)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1349 (LINC01349).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1349 (LINC01349).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call